Baseline multimodal information predicts future motor impairment in premanifest Huntington's disease

[1]  R. Reilmann,et al.  Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis , 2017, JAMA neurology.

[2]  Yogesh Rathi,et al.  Longitudinal diffusion changes in prodromal and early HD: Evidence of white‐matter tract deterioration , 2017, Human brain mapping.

[3]  Jane S. Paulsen,et al.  Patterns of Co-Occurring Gray Matter Concentration Loss across the Huntington Disease Prodrome , 2016, Front. Neurol..

[4]  Gary F. Egan,et al.  Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data , 2016, British Journal of Psychiatry.

[5]  G. Rees,et al.  Neuropsychiatry and White Matter Microstructure in Huntington’s Disease , 2015, Journal of Huntington's disease.

[6]  Jane S. Paulsen,et al.  Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT‐HD , 2015, Movement disorders : official journal of the Movement Disorder Society.

[7]  Adeel Razi,et al.  Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study , 2015, EBioMedicine.

[8]  Jane S. Paulsen,et al.  Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study , 2014, The Lancet Neurology.

[9]  Stefan Klöppel,et al.  Correction of inter-scanner and within-subject variance in structural MRI based automated diagnosing , 2014, NeuroImage.

[10]  Jane S. Paulsen,et al.  Huntington disease: natural history, biomarkers and prospects for therapeutics , 2014, Nature Reviews Neurology.

[11]  Jane S. Paulsen,et al.  Tracking motor impairments in the progression of Huntington's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[12]  Chris Frost,et al.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data , 2013, The Lancet Neurology.

[13]  Kira S. Sheinerman,et al.  Early detection of neurodegenerative diseases , 2013, Cell cycle.

[14]  Bruce Fischl,et al.  FreeSurfer , 2012, NeuroImage.

[15]  Jane S. Paulsen,et al.  Indexing disease progression at study entry with individuals at‐risk for Huntington disease , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[16]  Satrajit S. Ghosh,et al.  Nipype: A Flexible, Lightweight and Extensible Neuroimaging Data Processing Framework in Python , 2011, Front. Neuroinform..

[17]  Jane S. Paulsen,et al.  Neurocognitive signs in prodromal Huntington disease. , 2011, Neuropsychology.

[18]  Bruce Fischl,et al.  Highly accurate inverse consistent registration: A robust approach , 2010, NeuroImage.

[19]  Jeroen van der Grond,et al.  Early atrophy of pallidum and accumbens nucleus in Huntington’s disease , 2010, Journal of Neurology.

[20]  Vincent A Magnotta,et al.  Longitudinal change in regional brain volumes in prodromal Huntington disease , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  A. Lang.  Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future , 2010, Nature Medicine.

[22]  Stephen M. Smith,et al.  Age-related changes in grey and white matter structure throughout adulthood , 2010, NeuroImage.

[23]  Jane S. Paulsen,et al.  Striatal and white matter predictors of estimated diagnosis for Huntington disease , 2010, Brain Research Bulletin.

[24]  Nick C Fox,et al.  Pitfalls in the Use of Voxel-Based Morphometry as a Biomarker: Examples from Huntington Disease , 2010, American Journal of Neuroradiology.

[25]  Josephine Barnes,et al.  The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  Jane S. Paulsen,et al.  Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT‐HD study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[27]  Nick C Fox,et al.  Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data , 2009, The Lancet Neurology.

[28]  Stephen Smith,et al.  Schizophrenia delays and alters maturation of the brain in adolescence. , 2009, Brain : a journal of neurology.

[29]  L. Martinian,et al.  Quantitative grey matter histological measures do not correlate with grey matter probability values from in vivo MRI in the temporal lobe , 2009, Journal of Neuroscience Methods.

[30]  Jane S. Paulsen,et al.  Automatic detection of preclinical neurodegeneration , 2009, Neurology.

[31]  Jane S. Paulsen,et al.  Detection of Huntington’s disease decades before diagnosis: the Predict-HD study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[32]  Anne-Catherine Bachoud-Lévi,et al.  Distribution of grey matter atrophy in Huntington’s disease patients: A combined ROI-based and voxel-based morphometric study , 2006, NeuroImage.

[33]  Jane S. Paulsen,et al.  Preparing for preventive clinical trials: the Predict-HD study. , 2006, Archives of neurology.

[34]  Hanna Damasio,et al.  Methods for studying the aging brain: Volumetric analyses versus VBM , 2005, Neurobiology of Aging.

[35]  A. Dale,et al.  Effects of age on volumes of cortex, white matter and subcortical structures , 2005, Neurobiology of Aging.

[36]  H. Zou,et al.  Regularization and variable selection via the elastic net , 2005 .

[37]  J Kassubek,et al.  Topography of cerebral atrophy in early Huntington’s disease: a voxel based morphometric MRI study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[38]  C D Good,et al.  The distribution of structural neuropathology in pre-clinical Huntington's disease. , 2002, Brain : a journal of neurology.

[39]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[40]  M. MacDonald,et al.  CAG repeat number governs the development rate of pathology in Huntington's disease , 1997, Annals of neurology.

[41]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[42]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[43]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[44]  A Tikhonov,et al.  Solution of Incorrectly Formulated Problems and the Regularization Method , 1963 .